Autoimmune and non-autoimmune hyperthyroidism in pediatric patients: a review and personal commentary on management

Area of Science:

• Pediatric Endocrinology
• Thyroidology
• Internal Medicine

Background:

• Hyperthyroidism in pediatric patients presents unique challenges.
• Graves' disease is the predominant etiology in children and adolescents.
• Management strategies require careful consideration due to varying risks and outcomes.

Purpose of the Study:

• To comprehensively review the etiology, diagnosis, and management of pediatric hyperthyroidism.
• To discuss standard and adjunct treatment modalities for hyperthyroidism in neonates, infants, children, and adolescents.
• To highlight controversies and individualized treatment approaches.

Main Methods:

• Review of existing literature on pediatric hyperthyroidism.
• Analysis of diagnostic criteria and differential diagnoses.
• Evaluation of treatment options including antithyroid drugs, surgery, and radioiodine therapy.

Main Results:

• Graves' disease is the most common cause of pediatric hyperthyroidism.
• Current treatment options (medication, surgery, radioiodine) have associated risks and no single ideal approach.
• Less common causes and specific neonatal conditions require distinct management strategies.

Conclusions:

• Treatment selection for pediatric hyperthyroidism must be individualized, considering patient-specific factors.
• Further prospective, randomized outcome studies are needed to guide optimal treatment choices.
• A thorough understanding of both common and rare etiologies is crucial for effective management.